Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -17331.50x is 122% below its 2-year average of -7796.67x, near the low end of its 2-year range (-17331.50x–-0.41x).
As of the fiscal period ended Tuesday, December 31, 2013. 67.12% below its 12-month average of -10370.47x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2013 (2013-12-31): -17331.50x.
INTEREST COVERAGE RATIO
-17331.50x
INTEREST COVERAGE RATIO AVG TTM
-10370.47x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-67.12%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-269022.67%
vs the sector median at left
Traws Pharma, Inc.
Market Cap
$7.92M
Interest Coverage Ratio
-17331.50x
TTM Avg
-10370.47x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.87M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.04M
Interest Coverage Ratio
-97.81x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.05M
Interest Coverage Ratio
-17.73x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.75M
Interest Coverage Ratio
-1049.68x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.14M
Interest Coverage Ratio
-11.17x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.67M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.64M
Interest Coverage Ratio
-185.05x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.33M
Interest Coverage Ratio
-17.26x
TTM Avg
23.36x
3Y Avg
23.36x
5Y Avg
23.36x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | $7.92M | -17331.50x | -10370.47x | N/A | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.87M | N/A | N/A | N/A | N/A |
| GT Biopharma, Inc. (GTBP)vs › | $8.04M | -97.81x | N/A | N/A | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.05M | -17.73x | N/A | N/A | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | -1049.68x | N/A | N/A | N/A |
| HeartSciences Inc. (HSCS)vs › | $8.14M | -11.17x | N/A | N/A | N/A |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.67M | N/A | N/A | N/A | N/A |
| Mangoceuticals, Inc. (MGRX)vs › | $7.64M | -185.05x | N/A | N/A | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.33M | -17.26x | 23.36x | 23.36x | 23.36x |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.46M | N/A | N/A | N/A | N/A |
Interest Coverage
-17331.5x
Debt/Equity
N/A
Current Ratio
0.43
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2013-12-31 | -17331.50x |
| 2013-06-30 | -13779.50x |
| 2012-12-31 | -0.41x |
| 2012-06-30 | -75.27x |
